Amit V. Khera Profile
Amit V. Khera

@amitvkhera

Followers
5K
Following
7K
Media
389
Statuses
2K

Genomic medicine and clinical development @VerveTx by way of @MGHMedicine, @broadinstitute, @MGHCVFellows, @BrighamMedRes

Boston, MA
Joined February 2013
Don't wanna be here? Send us removal request.
@amitvkhera
Amit V. Khera
3 months
RT @VerveTx: We're pleased to announce positive initial data from the Heart-2 Phase 1b clinical trial of VERVE-102 demonstrating favorable….
0
23
0
@amitvkhera
Amit V. Khera
5 months
RT @HarvardCatalyst: Two-year advanced training award & mentorship program for senior fellows & junior faculty in c/t research.⁠ This award….
0
1
0
@amitvkhera
Amit V. Khera
5 months
RT @VerveTx: Our ultimate goal in protecting the world from cardiovascular disease is bringing low-density lipoprotein cholesterol (LDL-C),….
0
3
0
@amitvkhera
Amit V. Khera
7 months
RT @ourhealthstudy: On #GivingTuesday2024, consider supporting our efforts to discover and understand reasons why heart disease and diabete….
0
9
0
@amitvkhera
Amit V. Khera
7 months
RT @LabSpiegelman: Congratulations to our lab's newest NIH K-awardees Sumeet Khetarpal and Mu A! 🥳
Tweet media one
Tweet media two
0
1
0
@amitvkhera
Amit V. Khera
8 months
RT @VerveTx: Today, we announced pipeline progress and earnings from Q3 2024. Check out our latest updates: .👉 The Heart-2 Phase 1b clinica….
0
5
0
@amitvkhera
Amit V. Khera
8 months
RT @CVCTForum: #CVCT2024 : Join the discussion on GENE THERAPY FOR GENETIC AND FOR COMMON HEART DISEASES. PROGRESSING INTO CLINICAL STAGE,….
0
4
0
@amitvkhera
Amit V. Khera
9 months
RT @VerveTx: Our Vice President of Genomic Medicine @amitvkhera will be presenting at this year’s #ESGCT Annual Congress in Rome. He will d….
0
3
0
@amitvkhera
Amit V. Khera
9 months
RT @VerveTx: Cardiovascular disease is the leading cause of death globally, affecting people of all ages, genders, and backgrounds. At Verv….
0
3
0
@amitvkhera
Amit V. Khera
11 months
RT @skathire: 2Q Earnings @VerveTx . Continued progress:.1. Heart-2 trial testing VERVE-102 is enrolling . 2. Heart-2 and PCSK9 program da….
0
11
0
@amitvkhera
Amit V. Khera
11 months
RT @VerveTx: Today, we announced pipeline progress and earnings from Q2 2024 including updates on the Heart-2 clinical trial of VERVE-102,….
0
4
0
@amitvkhera
Amit V. Khera
11 months
RT @VerveTx: Ready to make your next career move? We are looking to add a Senior Scientist, Toxicologist to our growing team. Learn more fr….
0
1
0
@amitvkhera
Amit V. Khera
11 months
RT @ACCinTouch: Tomorrow is the last day to submit nominations for the Douglas P. Zipes Distinguished Young Scientist Award!. This award re….
0
4
0
@amitvkhera
Amit V. Khera
1 year
RT @DrMarthaGulati: A wonderful look at the future and the power of believing there is a new way of #CVPrev! .Thank you @VerveTx @skathire….
0
8
0
@amitvkhera
Amit V. Khera
1 year
RT @DanielJDrucker: The authors report that adherence to a healthy lifestyle (minimal obesogenic behaviors) is associated with a reduced ri….
0
31
0
@amitvkhera
Amit V. Khera
1 year
RT @EricTopol: How does a polygenic risk score for obesity (BMI) interact with 5 lifestyle factors for outcomes in >330,000 @uk_biobank par….
0
111
0
@amitvkhera
Amit V. Khera
1 year
RT @Marea_tx: Introducing Marea - a clinical-stage biotech on a mission to leverage large-scale human genetics and adipose biology to revol….
0
3
0
@amitvkhera
Amit V. Khera
1 year
RT @DrLoomba: Congratulations @AjmeraVeeral - strong work @MASLDResearch @UCSD_GI !.
0
2
0
@amitvkhera
Amit V. Khera
1 year
RT @LpaForum: @LpaForum benefits from a distinguished, international committee of experts, who will openly present and discuss their insigh….
0
5
0